These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6459500)

  • 21. [Effect of D1 and D2 dopamine receptor antagonists on acupuncture analgesia].
    Wang HH; Xu SF
    Sheng Li Xue Bao; 1993 Feb; 45(1):61-8. PubMed ID: 8503031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the vascular dopamine receptor with other dopamine receptors.
    Goldberg LI; Volkman PH; Kohli JD
    Annu Rev Pharmacol Toxicol; 1978; 18():57-79. PubMed ID: 348069
    [No Abstract]   [Full Text] [Related]  

  • 24. Classification of dopamine receptors.
    Creese I; Sibley DR; Leff S
    Adv Biochem Psychopharmacol; 1983; 37():255-66. PubMed ID: 6416028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dopamine receptor].
    Okuda M; Togashi S
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):707-17. PubMed ID: 2159172
    [No Abstract]   [Full Text] [Related]  

  • 26. [The suppressed pill with far-reaching consequences].
    Verhoeff NP
    Ned Tijdschr Geneeskd; 1992 Mar; 136(11):543. PubMed ID: 1532441
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cybernetic view of vasomotricity at the stage of terminal vascular bed].
    Merlen JF; Hiltenbrand C
    Phlebologie; 1970; 23(2):159-65. PubMed ID: 5448638
    [No Abstract]   [Full Text] [Related]  

  • 28. Flupentixol and dopamine receptor selectivity.
    Hyttel J
    Psychopharmacology (Berl); 1981; 75(2):217. PubMed ID: 6798610
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prolactin and the dopaminergic system in the pathogenesis of hypertension].
    Ziabreva EV; Bol'shakova TD; Gitel' EP
    Sov Med; 1985; (11):51-5. PubMed ID: 3911441
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dopamine receptors (author's transl)].
    Usuda S; Maeno H
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1592-9. PubMed ID: 6272361
    [No Abstract]   [Full Text] [Related]  

  • 31. Asymmetric total synthesis of tetrahydroprotoberberine derivatives and evaluation of their binding affinities at dopamine receptors.
    Lee DYW; Liu J; Zhang S; Huang P; Liu-Chen LY
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1437-1440. PubMed ID: 28214075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ; Harland D
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
    Kerns WD; Arena E; Morgan DG
    Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator.
    Bugelski PJ; Vockley CM; Sowinski JM; Arena E; Berkowitz BA; Morgan DG
    Br J Exp Pathol; 1989 Apr; 70(2):153-65. PubMed ID: 2567179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.
    Dumuis A; Sebben M; Monferini E; Nicola M; Turconi M; Ladinsky H; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):245-51. PubMed ID: 1650917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The vascular dopamine receptor : a review.
    Schmidt M; Imbs JL; Schwartz J
    J Pharmacol; 1981; 12(4):355-82. PubMed ID: 6459500
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular dopamine receptor as a model for other dopamine receptors.
    Goldberg LI
    Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioligand binding studies: evidence for multiple dopamine receptors.
    Creese I; Sibley DR
    Commun Psychopharmacol; 1979; 3(6):385-95. PubMed ID: 546587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.